Safety · 2026-04-14
Case Report: 7-OH Use Triggers Psychosis and Week-Long Delirium; Treated Successfully with Buprenorphine
Source: The Primary Care Companion for CNS Disorders
Why it matters
A documented case report shows that chronic high-dose 7-OH use can trigger psychosis, auditory/visual hallucinations, paranoia, and delirium persisting for days after cessation. This is the first clinical report of 7-OH-induced psychosis, indicating a need for clinicians to recognize 7-OH toxicity as a cause of unexplained psychiatric emergencies.
The big picture
While kratom is known to have opioid-like effects, 7-OH is 30 times more potent than kratom's primary alkaloid (mitragynine) and is now sold in 98% purity pills in gas stations and online. Unlike traditional kratom powder, synthetic 7-OH products lack quality control and can contain unknown alkaloid byproducts. Clinicians rarely consider 7-OH in differential diagnosis because standard urine drug screens don't detect it.
Key findings
- 62-year-old male with history of opioid use disorder developed suicidal ideation, auditory/visual hallucinations, paranoia, myoclonus, and confusion after months of 7-OH use (300-400+ mg/day)
- Symptoms persisted for nearly a week; routine labs, serum studies, and brain imaging were unremarkable
- Urine drug screen was negative for 7-OH (not detected by standard toxicology)
- Buprenorphine/naloxone initiated; suicidal ideation and hallucinations resolved within 24 hours; patient returned to baseline mental status by hospital day 5
- 7-OH is 100-fold more potent than mitragynine at mu-opioid receptors and lacks serotonin/adrenergic effects of mitragynine
What they say
"This case emphasizes the need for clinicians to consider 7-OH toxicity as a potential cause of unexplained altered mental status or new-onset psychosis and highlights the importance of a thorough substance use history as part of the medical workup," wrote the University of Nebraska clinical team.
Bottom line
7-OH-induced psychosis and delirium respond to buprenorphine, but clinicians must specifically ask about 7-OH use since it's not detected on standard drug screens.